PAX8 and renal cell carcinoma: The immunohistochemical (IHC) profile showed positivity for cytokeratin (CK) and carcinoembryonic antigen (CEA), with negativity for markers typically associated with RCC (e.g., PAX8, CD10) and urothelial carcinoma (e.g., GATA3, uroplakin).